灵芝
灵芝
传统医学
健康福利
生物活性
癌症
药品
药理学
化学
生物
计算生物学
生物化学
医学
体外
遗传学
作者
Emin Cadâr,Ticuţa Negreanu–Pîrjol,Carolina Pascale,Rodica Sîrbu,Irina Prasacu,Ticuţa Negreanu–Pîrjol,Cezar Laurențiu Tomescu,Ana María Ionescu
出处
期刊:Antioxidants
[Multidisciplinary Digital Publishing Institute]
日期:2023-10-25
卷期号:12 (11): 1907-1907
被引量:49
标识
DOI:10.3390/antiox12111907
摘要
Ganoderma lucidum (G. lucidum) has been known for many centuries in Asian countries under different names, varying depending on the country. The objective of this review is to investigate the scientific research on the natural active bio-compounds in extracts obtained from G. lucidum with significant biological actions in the treatment of cancer. This review presents the classes of bio-compounds existing in G. lucidum that have been reported over time in the main databases and have shown important biological actions in the treatment of cancer. The results highlight the fact that G. lucidum possesses important bioactive compounds such as polysaccharides, triterpenoids, sterols, proteins, nucleotides, fatty acids, vitamins, and minerals, which have been demonstrated to exhibit multiple anticancer effects, namely immunomodulatory, anti-proliferative, cytotoxic, and antioxidant action. The potential health benefits of G. lucidum are systematized based on biological actions. The findings present evidence regarding the lack of certainty about the effects of G. lucidum bio-compounds in treating different forms of cancer, which may be due to the use of different types of Ganoderma formulations, differences in the study populations, or due to drug–disease interactions. In the future, larger clinical trials are needed to clarify the potential benefits of pharmaceutical preparations of G. lucidum, standardized by the known active components in the prevention and treatment of cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI